Case Report

Chylothorax as a Result of Chronic Lymphocytic Leukemia: Case Report and Review of the Literature

Authors: Todd W. Rice, MD, Aaron P. Milstone, MD

Abstract

Chylothorax occurs when a disruption in the thoracic duct allows chyle to escape into the pleural space. The most commonly reported cause is malignancy, especially lymphoma. However, chylothorax caused by chronic lymphocytic leukemia is rarely reported in the literature. We describe a patient who developed chylothorax secondary to chronic lymphocytic leukemia. In addition, the pathogenesis, diagnosis, and treatment of chylothorax are reviewed.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Doerr CH, Staats BA, Markovic SN. Chylothorax in chronic lymphocytic leukemia patient. Am J Hematol 2002; 70: 237–240.
 
2. Ampil FL, Burton GV, Hardjasudarma M, et al. Chylous effusion complicating chronic lymphocytic leukemia. Leuk Lymphoma 1993; 10: 507–510.
 
3. Zimhony O, Davidovitch Y, Shtalrid M. Chronic lymphocytic leukaemia complicated by chylothorax. J Intern Med 1994; 235: 375–377.
 
4. Aranda EA, Aguinaco R. Chylothorax complicating chronic lymphocytic leukemia. Neth J Med 2001; 58: 223–224(letter).
 
5. Santos Gil I, Sanchez Molini P, Junquera Crespo M, et al. Chylothorax as a complication of chronic lymphatic leukemia [in Spanish]. Sangre (Barc) 1997; 42: 90–91(letter).
 
6. Light RW. Chylothorax and pseudochylothorax, in Pleural Diseases. Philadelphia, Lippincott Williams & Wilkins, 2001, ed 4, pp 327–343.
 
7. Staats BA, Ellefson RD, Budahn LL, et al. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 1980; 55: 700–704.
 
8. Breaux JR, Marks C. Chylothorax causing reversible T-cell depletion. J Trauma 1988; 28: 705–707.
 
9. Machleder HI, Paulus H. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Surgery 1978; 84: 157–165.
 
10. Al-Tawil K, Ahmed G, Al-Hathal M, et al. Congenital chylothorax. Am J Perinatol 2000; 17: 121–126.
 
11. Yoshida B, Tokeshi J. Chylothorax and cirrhosis of the liver: A case report. Hawaii Med J 2002; 61: 70–71, 81.
 
12. Villena V, de Pablo A, Martin-Escribano P. Chylothorax and chylous ascites due to heart failure. Eur Respir J 1995; 8: 1235–1236.
 
13. Parker JM, Torrington KG, Phillips YY. Sarcoidosis complicated by chylothorax. South Med J 1994; 87: 860–862.
 
14. Kaptanoglu M, Hatipoglu A, Kutluay L, et al. Bilateral chylothorax caused by pleuropulmonary lymphangiomyomatosis: A challenging problem in thoracic surgery. Scand Cardiovasc J 2001; 35: 151–154.
 
15. Morimoto N, Hirasaki S, Kamei T, et al. Pulmonary lymphangiomyomatosis (LAM) developing chylothorax. Intern Med 2000; 39: 738–741.
 
16. Ryu JH, Doerr CH, Fisher SD, et al. Chylothorax in lymphangioleiomyomatosis. Chest 2003; 123: 623–627.
 
17. Berkman N, Breuer R, Kramer MR, et al. Pulmonary involvement in lymphoma. Leuk Lymphoma 1996; 20: 229–237.
 
18. Klatte EC, Yardley J, Smith EB, et al. The pulmonary manifestations and complications of leukemia. AJR Am J Roentgenol 1963; 89: 598–609.
 
19. Jenkins PF, Ward MJ, Davies P, et al. Non-Hodgkin’s lymphoma, chronic lymphatic leukaemia and the lung. Br J Dis Chest 1981; 75: 22–30.
 
20. Ramos W, Faintuch J. Nutritional management of thoracic duct fistulas: A comparative study of parenteral versus enteral nutrition. JPEN J Parenter Enteral Nutr 1986; 10: 519–521.
 
21. Bruneau R, Rubin P. The management of pleural effusions and chylothorax in lymphoma. Radiology 1965; 85: 1085–1092.
 
22. Mares DC, Mathur PN. Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma: A case series. Chest 1998; 114: 731–735.
 
23. Fahimi H, Casselman FP, Mariani MA, et al. Current management of postoperative chylothorax. Ann Thorac Surg 2001; 71: 448–451.
 
24. Murphy MC, Newman BM, Rodgers BM. Pleuroperitoneal shunts in the management of persistent chylothorax. Ann Thorac Surg 1989; 48: 195–200.
 
25. Milsom JW, Kron IL, Rheuban KS, et al. Chylothorax: An assessment of current surgical management. J Thorac Cardiovasc Surg 1985; 89: 221–227.